Differential gene signatures in rat mammary tumors induced by DMBA and those induced by fractionated γ radiation

Radiation Research

Volumn 170, Issue 5, 2008, Pages 579-590

  Lee, Hae June ^a   Lee, Yoon Jin ^a   Kang, Chang Mo ^a   Bae, Sangwoo ^a   Jeoung, Dooil ^b   Jang, Ja June ^c   Lee, Seung Sook ^a   Cho, Chul Koo ^a   Lee, Yun Sil ^a  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Kangwon National University   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; CALCIUM CHANNEL; CATHEPSIN S; COMPLEMENTARY DNA; DIMETHYLBENZ[A]ANTHRACENE; HISTONE H2AX; HYPOCALCIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 18 BINDING PROTEIN; PROTEIN P53;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CELL STRUCTURE; CONTROLLED STUDY; DNA DAMAGE; DNA MICROARRAY; FEMALE; GAMMA RADIATION; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSFECTION; MUTATION; NICK END LABELING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIATION CARCINOGENESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TUMOR GENE; UNINDEXED SEQUENCE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL LINE, TUMOR; DNA DAMAGE; DOSE FRACTIONATION; FEMALE; GAMMA RAYS; GENE EXPRESSION PROFILING; HISTONES; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MEMBRANE PROTEINS; NEOPLASMS, RADIATION-INDUCED; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

RATTUS;

EID: 55549127909     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR1106.1     Document Type: Article

References (41)

1. D. Medina, Mammary tumorigenesis in chemical carcinogen-treated mice. II. Dependence on hormone stimulation for tumorigenesis. J. Natl. Cancer Inst. 53, 223-226 (1974).
2. D. Medina, Mammary tumorigenesis in chemical carcinogen-treated mice. I. Incidence in BALB-c and C57BL mice. J. Natl. Cancer Inst. 53, 213-221 (1974).
3. A. F. Trombino, R. I. Near, R. A. Matulka, S. Yang, L. J. Hafer, P. A. Toselli, D. W. Kim, A. E. Rogers, G. E. Sonenshein and D. H. Sherr, Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis. Breast Cancer Res. Treat. 63, 117-131 (2000).
4. D. W. Nebert, D. D. Petersen and A. J. Fornace, Jr., Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm. Environ. Health Perspect. 88, 13-25 (1990).
5. A. Rundle, D. Tang, H. Hibshoosh, A. Estabrook, F. Schnabel, W. Cao, S. Grumet and F. P. Perera, The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis 21, 1281-1289 (2000).
6. E. C. Miller and J. A. Miller, Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules. Pharmacol. Rev. 18, 805-838 (1966).
7. M. Tokunaga, C. E. Land, T. Yamamoto, M. Asano, S. Tokuoka, H. Ezaki and I. Nishimori, Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiat. Res. 112, 243-272 (1987).
8. A. Carmichael, A. S. Sami and J. M. Dixon, Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation. Eur. J. Surg. Oncol. 29, 475-479 (2003).
9. M. P. Little and J. D. Boice, Jr., Comparison of breast cancer incidence in the Massachusetts tuberculosis fluoroscopy cohort and in the Japanese atomic bomb survivors. Radiat. Res. 151, 218-224 (1999).
10. N. G. Hildreth, R. E. Shore and P. M. Dvoretsky, The risk of breast cancer after irradiation of the thymus in infancy. N. Engl. J. Med. 321, 1281-1284 (1989).
11. S. L. Hancock, M. A. Tucker and R. T. Hoppe, Breast cancer after treatment of Hodgkin's disease. J. Natl. Cancer Inst. 85, 25-31 (1993).
12. S. Bhatia, L. L. Robison, O. Oberlin, M. Greenberg, G. Bunin, F. Fossati-Bellani and A. T. Meadows, Breast cancer and other second neoplasms after childhood Hodgkin's disease. N. Engl. J. Med. 334, 745-751 (1996).
13. C. K. Wanebo, K. G. Johnson, K. Sato and T. W. Thorslund, Breast cancer after exposure to the atomic bombings of Hiroshima and Nagasaki. N. Engl. J. Med. 279, 667-671 (1968).
14. R. E. Shore, L. H. Hempelmann, E. Kowaluk, P. S. Mansur, B. S. Pasternack, R. E. Albert and G. E. Haughie, Breast neoplasms in women treated with x-rays for acute postpartum mastitis. J. Natl. Cancer Inst. 59, 813-822 (1977).
15. J. D. Boice, Jr., C. E. Land, R. E. Shore, J. E. Norman and M. Tokunaga, Risk of breast cancer following low-dose radiation exposure. Radiology 131, 589-597 (1979).
16. C. E. Land, J. D. Boice, Jr., R. E. Shore, J. E. Norman and M. Tokunaga, Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women. J. Natl. Cancer Inst. 65, 353-376 (1980).
17. F. G. Davis, J. D. Boice, Jr., Z. Hrubec and R. R. Monson, Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res. 49, 6130-6136 (1989).
18. B. Modan, A. Chetrit, E. Alfandary and L. Katz, Increased risk of breast cancer after low-dose irradiation. Lancet 1, 629-631 (1989).
19. F. A. Mettler, Jr., L. H. Hempelmann, A. M. Dutton, J. W. Pifer, E. T. Toyooka and W. R. Ames, Breast neoplasms in women treated with x rays for acute postpartum mastitis. A pilot study. J. Natl. Cancer Inst. 43, 803-811 (1969).
20. H. McGregor, C. E. Land, K. Choi, S. Tokuoka, P. I. Liu, T. Wakabayashi and G. W. Beebe, Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69. J. Natl. Cancer Inst. 59, 799-811 (1977).
21. M. Tokunaga, J. E. Norman, Jr., M. Asano, S. Tokuoka, H. Ezaki, I. Nishimori and Y. Tsuji, Malignant breast tumors among atomic bomb survivors, Hiroshima and Nagasaki, 1950-74. J. Natl. Cancer Inst. 62, 1347-1359 (1979).
22. R. Hilf, H. Goldenberg, M. Gruenstein, D. R. Meranze and M. B. Shimkin, Lack of correlation between morphological and biochemical parameters in mammary adenocarcinomas of rats induced with 7,12-dimethylbenz(a)anthracene. Cancer Res. 30, 1223-1230 (1970).
23. S. L. Tannheimer, F. T. Lauer, J. Lane and S. W. Burchiel, Factors influencing elevation of intracellular Ca2 in the MCF-10A human mammary epithelial cell line by carcinogenic polycyclic aromatic hydrocarbons. Mol. Carcinog. 25, 48-54 (1999).
24. N. D. Kauff and R. R. Barakat, Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2. J. Clin. Oncol. 25, 2921-2927 (2007).
25. K. Yoshida and Y. Miki, Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 95, 866-871 (2004).
26. M. R. Calderon and O. Paltiel, Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. Int. J. Cancer 112, 357-364 (2004).
27. G. Speit and K. Trenz, Chromosomal mutagen sensitivity associated with mutations in BRCA genes. Cytogenet. Genome Res. 104, 325-332 (2004).
28. J. J. Morris and E. Seifter, The role of aromatic hydrocarbons in the genesis of breast cancer. Med. Hypoth. 38, 177-184 (1992).
29. M. Tokunaga, C. E. Land and S. Tokuoka, Follow-up studies of breast cancer incidence among atomic bomb survivors. J. Radiat. Res. 32 (Suppl.), 201-211 (1991).
30. A. Mattsson, B. I. Ruden, P. Hall, N. Wilking and L. E. Rutqvist, radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease. J. Natl. Cancer Inst. 85, 1679-1685 (1993).
31. P. Mauch, Second malignancies after curative radiation therapy for good prognosis cancers. Int. J. Radiat. Oncol. Biol. Phys. 33, 959-960 (1995).
32. I. Benakanakere, C. Besch-Williford, J. Schnell, S. Brandt, M. R. Ellersieck, A. Molinolo and S. M. Hyder, Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats. Clin. Cancer Res. 12, 4062-4071 (2006).
33. K. El-Bayoumy and R. Sinha, Mechanisms of mammary cancer chemoprevention by organoselenium compounds. Mutat. Res. 551, 181-197 (2004).
34. M. Fedrowitz, K. Kamino and W. Loscher, Significant differences in the effects of magnetic field exposure on 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in two substrains of Sprague-Dawley rats. Cancer Res. 64, 243-251 (2004).
35. V. G. Gorgoulis, L. V. Vassiliou, P. Karakaidos, P. Zacharatos, A. Kotsinas, T. Liloglou, M. Venere, R. A. Ditullio, Jr., N. G. Kastrinakis and T. D. Halazonetis, Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907-913 (2005).
36. J. Bartkova, Z. Horejsi, K. Koed, A. Kramer, F. Tort, K. Zieger, P. Guldberg, M. Sehested, J. M. Nesland and J. Bartek, DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870 (2005).
37. M. A. Kadhim, D. A. Macdonald, D. T. Goodhead, S. A. Lorimore, S. J. Marsden and E. G. Wright, Transmission of chromosomal instability after plutonium alpha-particle irradiation. Nature 355, 738-740 (1992).
38. H. Okano, Y. Saito, T. Miyazawa, T. Shinbo, D. Chou, S. Kosugi, Y. Takahashi, S. Odani, O. Niwa and R. Kominami, Homozygous deletions and point mutations of the Ikaros gene in gamma-ray-induced mouse thymic lymphomas. Oncogene 18, 6677-6683 (1999).
39. N. Gonin-Laurent, A. Gibaud, M. Huygue, S. H. Lefevre, M. Le Bras, L. Chauveinc, X. Sastre-Garau, F. Doz, L. Lumbroso and B. Malfoy, Specific TP53 mutation pattern in radiation-induced sarcomas. Carcinogenesis 27, 1266-1272 (2006).
40. A. J. Sigurdson and I. M. Jones, Second cancers after radiotherapy: any evidence for radiation-induced genomic instability? Oncogene 22, 7018-7027 (2003).
41. M. S. Denison and S. R. Nagy, Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309-334 (2003).